ホーム › 2型糖尿病 › ネバダ州 › Las Vegas
Las Vegas、NVにおける2型糖尿病の臨床試験
Las Vegasとその周辺地域（約30マイル以内）の拠点で、2型糖尿病に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
被験者募集中第2相
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
被験者募集中第3相
- Palm Research Center Inc-Vegas, Las Vegas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
被験者募集中第3相
- Las Vegas Clinical Trials, Las Vegas
- AB Clinical Trials, Las Vegas
- Palm Research Center, Las Vegas
- 他2件
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
被験者募集中第3相
- Palm Research Center, Las Vegas
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
被験者募集中健康なボランティア歓迎
- Southwest Medical Associates- Optum Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Las Vegas
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
被験者募集中第2相
- DaVita Clinical Research, Las Vegas
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Las Vegas
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
被験者募集中第2相
- Alliance Clinical - Las Vegas, Las Vegas
- Palm Research Center, Inc., Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
被験者募集中第2相
- Vector Clinical Trials, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
被験者募集中第3相
- Palm Research Center Inc, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
被験者募集中第3相
- Research Site, Las Vegas
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
被験者募集中第3相
- Palm Research Center Inc-Vegas, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Las Vegas
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
被験者募集中第2相
- Santa Rosa Medical Centers of Nevada, Las Vegas
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
被験者募集中第2相
- Excel Clinical Research, Las Vegas
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
被験者募集中第2相
- Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
他の都市における2型糖尿病の試験
- San Antonio, TX37件の研究
- Houston, TX31件の研究
- Orlando, FL24件の研究
- Boston, MA20件の研究
- Miami, FL19件の研究
- Chicago, IL19件の研究
- Dallas, TX19件の研究
- Columbus, OH18件の研究
- Atlanta, GA17件の研究
- San Diego, CA17件の研究
- Los Angeles, CA16件の研究
- New York City, NY16件の研究
Las Vegasにおける他の研究
- 肥満症27件の研究
- 過体重23件の研究
- 非小細胞肺癌13件の研究
- 大うつ病性障害13件の研究
- 乳がん10件の研究
- アルツハイマー病8件の研究
- 前立腺がん8件の研究
- 急性骨髄性白血病8件の研究
- がん（全種類）8件の研究
- 脂肪肝7件の研究
- 子宮内膜がん7件の研究
- うつ病7件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。